FASN and esophageal squamous cell carcinoma: Our results shed new light on the dysregulated circHIPK3/miR-637/FASN axis during ESCC development and foresee that circHIPK3 may serve as a potential diagnostic marker and an effective therapeutic target for ESCC (Fig. 6W).